Skip to main content
. 2023 Mar 3;2023(3):CD014876. doi: 10.1002/14651858.CD014876.pub2

Comparison 2. Tapentadol versus no treatment or placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Constipation 1 15 Risk Ratio (M‐H, Fixed, 95% CI) 1.25 [0.06, 25.76]